Formulation development and evaluation of Telmisartan Nanoemulsion

Authors

  • Rajesh Kumar Department of Pharmaceutics, Institute of Pharmacy, Bundelkhand University Jhansi-284128 Uttar Pradesh India
  • Girish Chandra Soni Department of Pharmaceutics, Institute of Pharmacy, Bundelkhand University Jhansi-284128 Uttar Pradesh India
  • S.K. Prajapati Department of Pharmaceutics, Institute of Pharmacy, Bundelkhand University Jhansi-284128 Uttar Pradesh India

DOI:

https://doi.org/10.21276/IJRDPL.2278-0238.2017.6(4).2711-2719

Keywords:

Telmisartan, Nanoemulsion formulation, oil, surfactant, co-surfactant

Abstract

The aim of the present study was to development of oral nanoemulsion formulation of telmisartan belong to BCS class 2nd, It have low solubility and low permeability. Therefore, oral nanoemulsion containing Telmisartan was prepared to increase its solubility and bioavailability rate. The o/w nanoemulsion was prepared by screening the excipients from the nanoemulsion region of pseudo-ternary phase diagram. Oleic acid optimized as an oil phase based on higher solubility study. Surfactant (Tween 80) and co-surfactant (PEG 200) were mixed (Smix) in different volume ratios (1:1, 1:2, 1:3, 1:4, 2:1, 3:1..). The optimized formulation containing Oleic acid (13.6%), Tween 80 (23.9%), PEG 200 (7.9%) and Methanol (54.6%) as oil, surfactant, co-surfactant and aqueous phase in Smix was prepared. Formulated nanoemulsions has to be evaluated for UV, FTIR, in vitro drug release, viscosity, particle size, product stability at accelerated conditions compared to the conventional formulation. Optimized oral nanoemulsion showed increase bioavailability.

Downloads

Download data is not yet available.

References

Amani A, York P, Chrystyn H, Clark BJ, Do DQ; Determination of factors controlling the particle size in nanoemulsions using artificial neural networks. Eur.J.Pharm.Sci,2008, 35: 42-51. [View in PubMed]

Amidon GL, Lennernas H, Shah VP, Crison JR; A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res, 1995,12: 413-20. [View in PubMed]

Anderson BD; Chemical and related factors controlling lipid solubility. BT Gattefosse,1999,92: 11-8.

Attwood D, Mallon C, Ktistis G, Taylor CJ; A Study on factors influencing the droplet size in non-ionic oil-in-water microemulsions. Int.J.Pharm, 1992,88: 417-22.

Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S; Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta. Pharm, 2007, 57: 315-32.[View in PubMed]

Jafari, S.; He, Y.; Bhandari, B; Nano-emulsion production by sonication and micro-fluidization- a comparison. Int. J. Food Prop.2006, 9: 475-485.2.

Kentish, S.; Wooster, T.; Ashok Kumar, M.; Balachandran, S.; Mawson, R.; Simons, L; The use of ultrasonic for nanoemulsion preparation. Innovat. Food Sci. Emerg. Tech. 2008, 9, 170-175.

Narang AS, Delmarre D, Gao D; Stable drug encapsulation in micelles and microemulsions. Int. J. Pharm, 2007, 345: 9-25.[View in PubMed]

Porter CJH, Pouton CW, Cuine CF, Charman W; Enhancing intestinal drug solubilization using lipid-based delivery system. Adv. Drug Deliv. Rev,2008 60:673-91.[View in PubMed]

Sukanya M, Sai Kishore V; Design and Development of Solid dispersions of Simvastatin for Enhancing the Solubility. Ame.pharm.res, 2012, 2249-3387.

Subhashis Debnath, Gampa Vijay Kumar, Satyanarayana SV; Design, Development and Evaluation of Terbinafine HCl. Research J. Pharm and Tech,2012, 5(10).

Sintov AC, Shapiro L; New nanoemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo. J. Control Rel, 2004, 95: 173-83.

Subhashis D, Satyanarayanaanand, Gampa VK; Nanoemulsion-A Method to Improve the Solubility of Lipophilic Drugs. Int.J.rev.Pharm, 2231-0541, 2010.

Shafiq S, Shakeel F, Talegaonkar S, Ahmed FJ, Khar RK, Mushir A; Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm,2007, 66:227-43. [View in PubMed]

Shaji J, Joshi V; Self-microemulsifying drug delivery system (SMEDDS) for improving bioavailability of hydrophobic drugs and its potential to give sustained release dosage forms. Indian J. Pharm. Educ, 2005, 39(3): 130-5.

Tamilvanan S; Submicron emulsions as a carrier for topical (ocular and percutaneous) and nasal drug delivery. Indian J.Pharm. Educ, 38(2): 73-8, 2004.

Tadros, T.; Izquierdo, P.; Esquena, J.; Solans, C; Formation and stability of nano-emulsions. Adv. Colloid Interface Sci. 2004,108-109, 303-318. [View in PubMed]

Tadros TF, Belcher P; Encyclopaedia of emulsion technology, Marcel Dekker, New York, 1983,1: 129-285.

Published

2017-07-15

How to Cite

Kumar, R. ., Soni , G. C. ., & Prajapati, S. . (2017). Formulation development and evaluation of Telmisartan Nanoemulsion. International Journal of Research and Development in Pharmacy & Life Sciences, 6(4), 2711 - 2719. https://doi.org/10.21276/IJRDPL.2278-0238.2017.6(4).2711-2719